|
Status |
Public on Aug 24, 2014 |
Title |
Effect of Sunitinib treatment withdrawal on Immunodeficient mice bearing MDA-MB231 tumors |
Organism |
Mus musculus |
Experiment type |
Expression profiling by array
|
Summary |
Immunodeficient RAG1-/- mice bearing MDA-MB231-LUC+ tumors of 50-70 mm3 were daily administrated by gavage with vehicle (containing, 0.5% carboxymethylcellulose, 1.8 % NaCl, 0.4 % Tween-80, 0.9 %. benzyl alcohol, and ultrapure water adjusted to pH 6.0) or sunitinib (40mg/kg/day) for 30 days followed by treatment withdrawal for 3-4 weeks to allow the tumor regrowth until reaching the same volume as that of the vehicle treated group. Mice were sacrificed when tumor reached the volume of 350-400 mm3 and RNAs of two tumors from two different mice treated with sunitinib or vehicle were extracted.
|
|
|
Overall design |
One color experiment with 2 experimental conditions: Sunitinib vs Vehicle (n=2), corresponding to a total of 4 samples.
|
|
|
Contributor(s) |
Mari B, Barbry P, Lebrigand K, Noel A |
Citation(s) |
25017943 |
Submission date |
Sep 11, 2013 |
Last update date |
May 10, 2018 |
Contact name |
Kevin Lebrigand |
Organization name |
IPMC/CNRS
|
Lab |
Functional Genomics Platform of Nice-Sophia-Antipolis, France.
|
Street address |
660 route des lucioles
|
City |
Valbonne - Sophia-Antipolis |
ZIP/Postal code |
06560 |
Country |
France |
|
|
Platforms (1) |
GPL4134 |
Agilent-014868 Whole Mouse Genome Microarray 4x44K G4122F (Feature Number version) |
|
Samples (4)
|
|
Relations |
BioProject |
PRJNA218954 |